Valuation: Simcere Pharmaceutical Group Limited

Market Cap 3.46B 27.17B 3.14B 2.9B 2.62B 4.94B 327B 5.11B 34.87B 13.83B 174B 13B 12.72B 554B P/E 2026 *
13.4x
P/E 2027 * 11.4x
Enterprise Value 3.26B 25.61B 2.96B 2.74B 2.47B 4.65B 308B 4.82B 32.87B 13.03B 164B 12.25B 11.99B 522B EV / Sales 2026 *
2.14x
EV / Sales 2027 * 1.89x
Free-Float
33.7%
Yield 2026 *
4.01%
Yield 2027 * 4.55%
1 day-1.23%
1 week-6.70%
Current month+3.06%
1 month-5.17%
3 months-15.52%
6 months-6.53%
Current year-12.70%
1 week 10.42
Extreme 10.42
11.33
1 month 9.86
Extreme 9.86
11.38
Current year 9.07
Extreme 9.07
14.28
1 year 9.07
Extreme 9.07
14.34
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
Manager TitleAgeSince
Chief Executive Officer 63 20/08/2026
Chief Executive Officer 54 25/03/2026
Director of Finance/CFO 55 19/11/2019
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
Date Insider Type Main position Quantity % Market Cap. Importance
28/10/26 Other

Chief Executive Officer

200,000 0.0078%
28/10/26 Other

Director

200,000 0.0078%
20/8/26 Other

Chairperson

-3,000,000 0.1168%
Change 5-day change 1-year change 3-year change Capi.($)
-0.66%-6.70%-24.17%+45.14% 3.46B
+1.26%+6.61%+40.79%+145.27% 1,286B
+0.79%+3.45%+45.84%+92.04% 688B
+0.20%+1.28%+26.97%+114.41% 521B
-0.44%+3.69%+41.45%+70.04% 386B
+0.55%+0.70%+59.02%+45.79% 364B
-0.12%+0.74%+28.39%+60.32% 302B
+0.37%+0.37%+3.33%+38.57% 287B
-0.30%+1.14%+38.29%+70.56% 252B
+0.08%+0.71%+34.44%+123.99% 208B
Average +0.12%+1.41%+29.44%+80.61% 430B
Weighted average by Cap. +0.54%+3.25%+37.65%+99.24%

Financials

2026 *2027 *
Net sales 1.52B 11.95B 1.38B 1.28B 1.15B 2.17B 144B 2.25B 15.34B 6.08B 76.74B 5.72B 5.6B 244B 1.76B 13.81B 1.6B 1.48B 1.33B 2.51B 166B 2.6B 17.72B 7.03B 88.66B 6.61B 6.47B 281B
Net income 257M 2.02B 233M 216M 195M 367M 24.25B 379M 2.59B 1.03B 12.95B 965M 945M 41.12B 304M 2.39B 276M 255M 230M 433M 28.67B 449M 3.06B 1.21B 15.31B 1.14B 1.12B 48.61B
Net Debt -199M -1.56B -180M -167M -150M -283M -18.75B -293M -2B -794M -10.02B -746M -731M -31.8B -141M -1.11B -128M -118M -107M -201M -13.28B -208M -1.42B -562M -7.09B -529M -517M -22.52B
Projected Income Statement - Annual - Simcere Pharmaceutical Group Limited
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is an investment holding company primarily engaged in the research and development, manufacturing and sales of pharmaceutical products. The Company mainly operates its business through two segments. The Anti-oncology Business segment is mainly engaged in the research and development, manufacturing, sales and commercialization of anti-oncology pharmaceuticals. The Other Pharmaceutical Business segment is mainly engaged in the research and development, manufacturing, sales and commercialization of pharmaceuticals with focus on the multiple therapeutic areas including neuroscience, autoimmune and anti-infection. The Company is also engaged in providing rendering commercialization service of pharmaceutical products. The Company mainly conducts its business in the domestic market.
Employees
7,064
Date Price Change Volume
16/11/26 HK$10.52 -0.57% 504,000
13/11/26 HK$10.58 -2.85% 2,365,537
12/11/26 HK$10.89 -0.18% 2,500,600
11/11/26 HK$10.91 -1.09% 3,201,000
10/11/26 HK$11.03 -1.52% 2,523,540
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Simcere Pharmaceutical Group Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
9.002CNY
Average target price
16.58CNY
Spread / Average Target
+84.20%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Simcere Pharmaceutical Group Limited
  1. Stock Market
  2. Stocks
  3. 2096 Stock